MedPath

Invitation strategies for colorectal (CRC) screening programmes - The impact of an advance notification letter

Not Applicable
Completed
Conditions
Colorectal cancer screening
Cancer
Malignant neoplasm of colon, Malignant neoplasm of rectum
Registration Number
ISRCTN84448636
Lead Sponsor
ASR Abruzzo (Italy)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
60000
Inclusion Criteria

All subjects (male and female) aged 50 to 69 targeted for CRC screening in 8 population based programmes in Italy, using immunochemical fecal occult blood test (FIT) in 5 cases (biennial screening offered to subjects aged 50 to 69), or sigmoidoscopy (FS) in 3 cases (FS offered once in the lifetime to all subjecst aged 58-60)

Exclusion Criteria

1. People with personal or family (>1 first degree relative with CRC) of CRC
2. Inflammatory bowel disease
3. Inability to give an informed consent
4. Severe life-threatening disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Participation rate at 6 months from the invitation letter by study group and screening strategy (FIT and FS)
Secondary Outcome Measures
NameTimeMethod
1. Participation rate at 6 months from the invitation stratified by previous screening history (FIT programmes only)<br>2. Costs of the different options<br>3. GP's workload and proportion of subjects who accept the offer of a personal encounter
© Copyright 2025. All Rights Reserved by MedPath